Nephrology · Alhambra, CA
NPI
1518913037
Since 2006
Specialty
Nephrology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
328 S 1st St, 2nd Floor
Alhambra, CA, 91801
Phone (626) 281-1903
Groups this clinician bills Medicare through
Medicare paid, 2024
$585K
3,876 services
Medicare patients, 2024
564
Average age 75
Drug cost, 2024
$3.0M
10,237 prescriptions
Company payments, 2025
$813
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lakhi M Sakhrani was code 99233 (hospital e&m - subsequent), 1,002 times for 164 patients. In total Lakhi M Sakhrani billed 3,876 services in 18 codes, and Medicare paid $585K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,002 | 164 | $97.79 | $98K |
| 90960 ESRD Related Services (not dialysis) | Office | 861 | 119 | $290.60 | $250K |
| 99214 Office E&M - Established | Office | 493 | 212 | $109.03 | $54K |
| 99232 Hospital E&M - Subsequent | Facility | 425 | 56 | $63.98 | $27K |
| 99291 Critical Care E&M | Facility | 270 | 67 | $172.88 | $47K |
| 99223 Hospital E&M - Initial | Facility | 204 | 159 | $142.14 | $29K |
| 99443 Telephone Services | Office | 114 | 82 | $77.33 | $8,815 |
| 90961 ESRD Related Services (not dialysis) | Office | 101 | 61 | $242.38 | $24K |
| 99213 Office E&M - Established | Office | 95 | 72 | $60.38 | $5,736 |
| 90966 ESRD Related Services (not dialysis) | Office | 95 | 18 | $236.29 | $22K |
| 90935 Hemodialysis | Facility | 44 | 31 | $58.19 | $2,561 |
| 99441 Telephone Services | Office | 42 | 38 | $17.81 | $748 |
| 99233 Hospital E&M - Subsequent | Office | 33 | 20 | $97.79 | $3,227 |
| 99204 Office E&M - New | Office | 27 | 27 | $142.95 | $3,860 |
| 99442 Telephone Services | Office | 26 | 25 | $26.77 | $696 |
By year: 2022 $658K for 5,003 services; 2023 $656K for 5,594 services; 2024 $585K for 3,876 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 50 | 39 | $8.40 | $420 |
Medicare prescription drug claims, 2024
In 2024, the drug Lakhi M Sakhrani prescribed most often to Medicare patients was Losartan Potassium, with 667 prescriptions and refills. In total Lakhi M Sakhrani wrote 10,237 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 667 | 1,014 | 162 | $3,656 |
| Farxiga Dapagliflozin Propanediol | 546 | 645 | 107 | $351K |
| Amlodipine Besylate Generic | 428 | 647 | 107 | $1,410 |
| Calcium Acetate Generic | 391 | 435 | 78 | $15K |
| Jardiance Empagliflozin | 365 | 400 | 88 | $227K |
| Furosemide Generic | 362 | 468 | 87 | $1,214 |
| Procrit Epoetin Alfa | 324 | 325 | 63 | $354K |
| Atorvastatin Calcium Generic | 314 | 492 | 58 | $1,543 |
| Pantoprazole Sodium Generic | 309 | 397 | 70 | $1,827 |
| Sevelamer Carbonate Generic | 211 | 257 | 44 | $41K |
| Prednisone Generic | 194 | 278 | 33 | $801 |
| Metoprolol Succinate Generic | 183 | 247 | 35 | $1,183 |
| Lokelma Sodium Zirconium Cyclosilicate | 180 | 193 | 42 | $141K |
| Levothyroxine Sodium Generic | 165 | 247 | 28 | $1,218 |
| Tamsulosin Hcl Generic | 163 | 236 | 35 | $1,282 |
Brand drugs: 2,625 claims; generic drugs: 7,500 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lakhi M Sakhrani $813 ($813 in general payments such as food, travel and fees) from 11 companies. The largest payer was Mannkind Corporation with $196.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 12 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $144 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $119 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $75.82 |
| Fresenius USA Marketing, Inc. | 3 | $59.83 |
| Scpharmaceuticals Inc. SCPH | 2 | $52.05 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $49.82 |
| Travere Therapeutics, Inc. TVTX | 5 | $45.93 |
| Calliditas Therapeutics US Inc. | 2 | $31.99 |
| Lilly USA, LLC LLY | 1 | $23.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.